首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Bone Marrow Transplantation

Bone Marrow Transplantation杂志,由Springer Nature出版,于1997年创刊,Semimonthly,出版语言English,ISSN:0268-3369,E-ISSN:1476-5365。

投稿咨询
Bone Marrow Transplantation
Bone Marrow Transplantation
Bone Marrow Transplantation
SCI SCIE

杂志介绍

JCR分区
Q1
中科院分区
2区
影响因子
5.1
CiteScore
7.6
期刊收录
SCI、SCIE

Bone Marrow Transplantation(中文译名:《骨髓移植》),ISSN:0268-3369,EISSN:1476-5365,是Springer Nature出版的国际性学术期刊,创刊于1997年,以Semimonthly形式稳定发行,2026年总发文量约145篇。该刊采用非OA开放访问,学科归属为医学 - 免疫学。该刊是医学、肿瘤学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达5.1,2025年期刊CiteScore为7.6,2025年期刊自引率约9.8%,在中科院期刊分区体系中位列医学大类2区,在所属学科领域具备高学术影响力与国际认可度。Bone Marrow Transplantation长期聚焦医学、肿瘤学及相关产业的技术应用前沿,平均审稿周期一般,3-8周,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、肿瘤学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USAGERMANY (FED REP GER)、Italy、Spain、England、France、Netherlands等为核心发文国家与地区;ASSISTANCE PUBLIQUE HOPITAUX PARIS (APHP)SORBONNE UNIVERSITE、INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)、UNICANCER、UNIVERSITY OF HAMBURG、UNIVERSITE DE PARIS、UNIVERSITY OF LONDON等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
ONCOLOGY 肿瘤学 HEMATOLOGY 血液学 IMMUNOLOGY 免疫学 TRANSPLANTATION 移植
2区 2区 2区 2区
否 否

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
HEMATOLOGY 血液学 IMMUNOLOGY 免疫学 TRANSPLANTATION 移植 ONCOLOGY 肿瘤学
2区 2区 2区 3区
否 否

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
TRANSPLANTATION 移植 HEMATOLOGY 血液学 IMMUNOLOGY 免疫学 ONCOLOGY 肿瘤学
2区 3区 3区 3区
否 否

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:HEMATOLOGY SCIE Q1 18 / 103

83

学科:IMMUNOLOGY SCIE Q2 51 / 183

72.4

学科:ONCOLOGY SCIE Q1 83 / 333

75.2

学科:TRANSPLANTATION SCIE Q1 4 / 30

88.3

学科:HEMATOLOGY SCIE Q1 19 / 103

82.04

学科:IMMUNOLOGY SCIE Q1 40 / 183

78.42

学科:ONCOLOGY SCIE Q1 76 / 333

77.33

学科:TRANSPLANTATION SCIE Q2 8 / 30

75

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:HEMATOLOGY SCIE Q1 16 / 99

84.3

学科:IMMUNOLOGY SCIE Q1 41 / 183

77.9

学科:ONCOLOGY SCIE Q1 64 / 328

80.6

学科:TRANSPLANTATION SCIE Q1 4 / 31

88.7

学科:HEMATOLOGY SCIE Q1 20 / 100

80.5

学科:IMMUNOLOGY SCIE Q2 47 / 183

74.59

学科:ONCOLOGY SCIE Q2 83 / 328

74.85

学科:TRANSPLANTATION SCIE Q2 8 / 31

75.81


中国学者近期发文

1
Second alternative-donor haploidentical stem cell transplantation enhances survival in patients with myeloid malignancies complicated by posttransplant human leukocyte antigen loss relaps

Author:Chen, Xiao-Tong; Shi, Ze-Chang; Wang, Yu; Zhang, Xiao-Hui; Chen, Huan; Chen, Yu-Hong; Wang, Feng-Rong; Sun, Yu-Qian; Yan, Chen-Hua; Lv, Meng; Mo, Xiao-Dong; Zhao, Xiao-Su; Huang, Xiao-Jun; Chang, Ying-Jun; Huo, Ming-Rui

Journal: BONE MARROW TRANSPLANTATION. 2026; Vol. , Issue , pp. -. DOI: 10.1038/s41409-026-02859-4

2
Bringing the rare into sight: applications of haploidentical stem cell transplantation in the treatment of rare disease

Author:Ma, Xiao-Di; Xu, Zheng-Li; Huang, Xiao-Jun

Journal: BONE MARROW TRANSPLANTATION. 2026; Vol. , Issue , pp. -. DOI: 10.1038/s41409-026-02839-8

3
Management of tyrosine kinase inhibitors and donor lymphocyte infusions post transplantation for chronic myeloid leukemia: a survey of contemporary practice on behalf of the chronic malignancies working party of the EBM

Author:Kanellopoulos, Alexandros; Koster, Linda; de Lavallade, Hugues; Ortí, Guillermo; Francis, Sebastian; Passweg, Jakob; Apperley, Jane; Bethge, Wolfgang; Rabitsch, Werner; Clay, Jennifer; Forcade, Edouard; Hurst, Erin; Besley, Caroline; Kinsella, Francesca; Aljurf, Mahmoud; Huang, He; Ho, Aloysius; Hilgendorf, Inken; Choi, Goda; Ayuk, Francis; Grzegorz, Helbig; Stelljes, Matthias; Richardson, Deborah; Morozova, Elena; Prejzner, Witold; Zeiser, Robert; Armstrong, Christopher; Raj, Kavita; Drozd-Sokolowska, Joanna; Chalandon, Yves; McLornan, Donal P

Journal: BONE MARROW TRANSPLANTATION. 2026; Vol. , Issue , pp. -. DOI: 10.1038/s41409-026-02862-9

4
Chronic graft-versus-host disease after haploidentical transplantation in aplastic anemia: clinical characteristics, risk factors, and survival outcome

Author:Lin, Ming-Hao; Gao, Sheng-Nan; Huang, Xiao-Jun; Xu, Lan-Ping; Fu, Hai-Xia; Cheng, Yi-Fei; Han, Ting-Ting; Zhang, Yuan-Yuan; Mo, Xiao-Dong; Sun, Yu-Qian; Wang, Yu; Zhang, Xiao-Hui; Xu, Zheng-Li

Journal: BONE MARROW TRANSPLANTATION. 2026; Vol. , Issue , pp. -. DOI: 10.1038/s41409-026-02855-8

5
Sequential CD19/CD22 CAR-T cell therapy following ASCT shows improved efficacy versus CAR-T alone in relapsed/refractory large B-cell lymphom

Author:Li, Jiaqi; Feng, Shanglong; Jia, Sixun; Zhang, Ying; Hua, Yuchen; Geng, Hongzhi; Chen, Jia; Kang, Liqing; Yu, Lei; Xu, Ting; Bao, Xiebing; Wu, Depei; Li, Caixia

Journal: BONE MARROW TRANSPLANTATION. 2026; Vol. , Issue , pp. -. DOI: 10.1038/s41409-026-02858-5

6
Donor age ≥50 years combined with donor-CI ≥3 identifies a high-risk cohort for adverse outcomes after allogeneic hematopoietic stem cell transplantation in B-cell acute lymphoblastic leukemi

Author:Wu, Ning; Kong, Jun; Lv, Meng; Mo, Xiao-Dong; Sun, Yu-Qian; Cheng, Yi-Fei; Xu, Lan-Ping; Zhang, Xiao-Hui; Huang, Xiao-Jun; Wang, Yu

Journal: BONE MARROW TRANSPLANTATION. 2026; Vol. , Issue , pp. -. DOI: 10.1038/s41409-026-02844-x

7
Is sex chromosome loss a predictive marker for outcome after sex-mismatched allogeneic hematopoietic stem cell transplantation

Author:Gao, Lu; Li, Na; Feng, Lin; Zhang, Xiaohui; Xu, Lanping; Wang, Yu; Chang, Yingjun; Huang, Xiaojun; Lai, Yueyun

Journal: BONE MARROW TRANSPLANTATION. 2026; Vol. , Issue , pp. -. DOI: 10.1038/s41409-026-02828-x

8
Differential clinical impact of HLA-DPA1∼DPB1 linkage mismatches in 14/14-matched unrelated donor HSCT: a multicenter retrospective study from CMDP revealing age- and disease-specific risk pattern

Author:Zhang, Tengteng; Bao, Xiaojing; Han, Ying; Yuan, Xiaoni; Li, Yang; Jiang, Xue; Yang, Tianjie; Du, Dan; He, Jun

Journal: BONE MARROW TRANSPLANTATION. 2026; Vol. , Issue , pp. -. DOI: 10.1038/s41409-026-02835-y

9
The safety and efficacy of belumosudil and ruxolitinib combination in ruxolitinib refractory cGVH

Author:Wu, Yibo; Liu, Lizhen; Chen, Yi; Lai, Xiaoyu; Chen, Yan; Lu, Ying; Yang, Luxin; Sun, Lan; He, Jiayi; Tong, Fenfang; Cao, Junjie; Li, Lin; Shi, Jimin; Zhao, Yanmin; Yuan, Xiaolin; Zhu, Panpan; Huang, He; Xu, Yajing; Luo, Yi

Journal: BONE MARROW TRANSPLANTATION. 2026; Vol. , Issue , pp. -. DOI: 10.1038/s41409-026-02848-7

10
Incidence and outcome of hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: a survey of the infectious diseases working party of EBM

Author:Cesaro, Simone; Garonzi, Chiara; Tridello, Gloria; Verheggen, Inge; Liu, Daihong; Flynn, Catherine; Alahmari, Ali; Kaynar, Leylagul; Rabitsch, Werner; Uygun, Vedat; Chorao, Pedro; Hu, Jiong; Esquirol, Albert; Pinana, Jose Luis; Aljurf, Mahmoud; Wagner-Drouet, Eva; Lang, Peter; Martin-Sanchez, Guillermo; Ratip, Siret; Facchini, Luca; Nasilowska-Adamska, Barbara; Styczynski, Jan; Ram, Ron; Metafuni, Elisabetta; Tanase, Alina; Kalwak, Krzysztof; Serio, Bianca; Hashem, Hasan; Castagna, Luca; Vicent, Marta Gonzalez; Karakukcu, Musa; Halahleh, Khaled; Baltadakis, Ioannis; Benedetti, Edoardo; Mikulska, Malgorzata; De La Camara, Rafael; Averbuch, Dina

Journal: BONE MARROW TRANSPLANTATION. 2026; Vol. , Issue , pp. -. DOI: 10.1038/s41409-026-02832-1


在线咨询

Bone Marrow Transplantation

国际简称:BONE MARROW TRANSPL参考译名:骨髓移植

年发文量:145 CiteScore:7.6 是否预警:否 Gold OA文章占比:36.08% 研究类文章占比:90.34%

杂志社联系方式:NATURE PUBLISHING GROUP, MACMILLAN BUILDING, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW

Bone Marrow Transplantation